Cardiff Oncology (CRDF) SEC Filings & 10K Form $2.71 -0.03 (-1.09%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$2.80 +0.09 (+3.14%) As of 09:28 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Cardiff Oncology SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/23/20257:19 PMBlackRock, Inc. (Filed by)Cardiff Oncology, Inc. (Subject)Cardiff Oncology (Subject)Form SCHEDULE 13G02/27/20253:11 PMCardiff Oncology, Inc. (Filer)Cardiff Oncology (Filer)Form S-3Registration statement under Securities Act of 1933 02/27/20253:15 PMCardiff Oncology, Inc. (Filer)Cardiff Oncology (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/27/20253:00 PMCardiff Oncology, Inc. (Filer)Cardiff Oncology (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 02/12/20251:48 PMCardiff Oncology, Inc. (Subject)Cardiff Oncology (Subject)PFIZER INC (Filed by)Form SCHEDULE 13G/A12/18/20243:37 PMCardiff Oncology, Inc. (Issuer)Cardiff Oncology (Issuer)Levine James E. (Reporting)Form 4Statement of changes in beneficial ownership of securities 12/17/20243:06 PMCardiff Oncology, Inc. (Subject)Cardiff Oncology (Subject)COMMODORE CAPITAL LP (Filed by)Form SCHEDULE 13G12/16/20244:00 PMCardiff Oncology, Inc. (Issuer)Cardiff Oncology (Issuer)TANNENBAUM RENEE P (Reporting)Form 4Statement of changes in beneficial ownership of securities 12/11/20245:15 AMCardiff Oncology, Inc. (Filer)Cardiff Oncology (Filer)Form 424B512/10/20245:02 AMCardiff Oncology, Inc. (Filer)Cardiff Oncology (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/24/20241:02 PMBlackRock, Inc. (Filed by)Cardiff Oncology, Inc. (Subject)Cardiff Oncology (Subject)Form SC 13G06/17/20245:10 AMCardiff Oncology, Inc. (Filer)Cardiff Oncology (Filer)Form DEFA14A06/03/20243:06 PMCardiff Oncology, Inc. (Filer)Cardiff Oncology (Filer)Form DEFA14A(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Xencor SEC Filings Anavex Life Sciences SEC Filings AbCellera Biologics SEC Filings Day One Biopharmaceuticals SEC Filings CureVac SEC Filings uniQure SEC Filings Praxis Precision Medicines SEC Filings Immunome SEC Filings Bicara Therapeutics SEC Filings Replimune Group SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:CRDF) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiff Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiff Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRDF Stock Free CRDF Stock Alerts